Neurocrine Biosciences Inc

MORGAN STANLEY NBIX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,209,378

Value ($000)

171,527

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	171,527	0.0%	1,209,378	12/31/2025
2025 Q3	11/14/2025	256,466	0.0%	1,826,937	9/30/2025
2025 Q2	8/14/2025	228,724	0.0%	1,819,745	6/30/2025
2025 Q1	5/15/2025	167,917	0.0%	1,518,237	3/31/2025
2024 Q4	5/15/2025	214,756	0.0%	1,573,297	12/31/2024
2024 Q3	5/14/2025	155,476	0.0%	1,349,381	9/30/2024
2024 Q2	5/14/2025	212,682	0.0%	1,544,869	6/30/2024
2024 Q1	5/15/2024	284,893	0.0%	2,065,636	3/31/2024
2023 Q4	2/13/2024	306,513	0.0%	2,326,294	12/31/2023
2023 Q3	11/15/2023	216,459	0.0%	1,924,079	9/30/2023
2023 Q2	8/14/2023	176,155	0.0%	1,868,025	6/30/2023
2023 Q1	5/15/2023	167,508	0.0%	1,654,893	3/31/2023
2022 Q4	2/14/2023	244,623	0.0%	2,048,085	12/31/2022
2022 Q3	11/14/2022	57,010	0.0%	536,778	9/30/2022
2022 Q2	10/27/2022	47,500	0.0%	487,275	6/30/2022
2022 Q1	10/27/2022	16,577	0.0%	176,827	3/31/2022
2021 Q4	2/14/2022	11,871	0.0%	139,365	12/31/2021
2021 Q3	11/15/2021	13,898	0.0%	144,891	9/30/2021
2021 Q2	8/23/2021	34,023	0.0%	349,600	6/30/2021
2021 Q1	5/17/2021	10,718	0.0%	110,217	3/31/2021
2020 Q4	2/16/2021	11,989	0.0%	125,073	12/31/2020
2020 Q3	11/13/2020	27,230	0.0%	283,182	9/30/2020
2020 Q2	8/14/2020	17,773	0.0%	145,679	6/30/2020
2020 Q1	5/26/2020	7,048	0.0%	81,431	3/31/2020
2019 Q4	2/14/2020	17,144	0.0%	159,499	12/31/2019
2014 Q1	5/13/2014	340	0.0%	21,120	3/31/2014
2013 Q4	2/13/2014	467	0.0%	49,998	12/31/2013